Jemma B. Wilk, Xiaoyin Shan, Christine S. Moravec, Christopher Newton-Cheh, Stella Trompet, Eric Boerwinkle, Javed Butler, Julius S. Ngwa, Laurie A. Boyer, Michael Morley, Nona Sotoodehnia, Nicholas L. Smith, Howard D. Sesso, David J. Stott, David Aguilar, Ying A. Wang, Ian Ford, Kenneth B. Margulies, Kent D. Taylor, André G. Uitterlinden, Jeffrey Brandimarto, Xinchen Wang, Joshua C. Bis, J. Michael Gaziano, Manolis Kellis, Janine F. Felix, Chunyu Liu, Symen Ligthart, Björn Olde, Luc Djoussé, Abbas Dehghan, Serkalem Demissie, Michael M. Mendelson, Roby Joehanes, J. Wouter Jukema, Bruce M. Psaty, Brendan M. Buckley, Marketa Sjögren, Ramachandran S. Vasan, J. Gustav Smith, Stephen B. Kritchevsky, Bruno H. Stricker, Daniel Levy, Andreas P. Kalogeropoulos, Olof Gidlöf, Alanna C. Morrison, Albert Hofman, Kenneth Rice, Oscar H. Franco, Yongmei Liu, L. Adrienne Cupples, Pim van der Harst, Chen Yao, Joyce B. J. van Meurs, Thomas P. Cappola, Cardiovascular Centre (CVC), Massachusetts Institute of Technology. Department of Biology, Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science, Wang, Xinchen, Kellis, Manolis, Boyer, Laurie Ann, Epidemiology, Internal Medicine, and Medical Informatics
Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a meta-analysis of genome-wide association studies and follow-up genotyping in independent populations. We identified and replicated an association for a genetic variant on chromosome 5q22 with 36% increased risk of death in subjects with heart failure (rs9885413, P = 2.7x10⁻⁹. We provide evidence from reporter gene assays, computational predictions and epigenomic marks that this polymorphism increases activity of an enhancer region active in multiple human tissues. The polymorphism was further reproducibly associated with a DNA methylation signature in whole blood (P = 4.5x10⁻⁴⁰) that also associated with allergic sensitization and expression in blood of the cytokine TSLP (P = 1.1x10⁻⁴). Knockdown of the transcription factor predicted to bind the enhancer region (NHLH1) in a human cell line (HEK293) expressing NHLH1 resulted in lower TSLP expression. In addition, we observed evidence of recent positive selection acting on the risk allele in populations of African descent. Our findings provide novel genetic leads to factors that influence mortality in patients with heart failure., National Heart, Lung, and Blood Institute (HHSN268201100005C), National Heart, Lung, and Blood Institute (HHSN268201100006C), National Heart, Lung, and Blood Institute (HHSN268201100007C), National Heart, Lung, and Blood Institute (HHSN268201100008C), National Heart, Lung, and Blood Institute (HHSN268201100009C), National Heart, Lung, and Blood Institute (HHSN268201100010C), National Heart, Lung, and Blood Institute (HHSN268201100011C), National Heart, Lung, and Blood Institute (HHSN268201100012C), National Heart, Lung, and Blood Institute (N01-HC-55015), National Heart, Lung, and Blood Institute (N01-HC-55016), National Heart, Lung, and Blood Institute (N01-HC-55018), National Heart, Lung, and Blood Institute (N01-HC-55019), National Heart, Lung, and Blood Institute (N01-HC-55020), National Heart, Lung, and Blood Institute (N01-HC-55021), National Heart, Lung, and Blood Institute (N01-HC-55022), National Heart, Lung, and Blood Institute (R01HL087641), National Heart, Lung, and Blood Institute (R01HL59367), National Heart, Lung, and Blood Institute (R01HL086694), National Human Genome Research Institute (U.S.) (U01HG004402), United States. National Institutes of Health (HHSN268200625226C), United States. National Institutes of Health (UL1RR025005), National Heart, Lung, and Blood Institute (HHSN268201200036C), National Heart, Lung, and Blood Institute (N01HC55222), National Heart, Lung, and Blood Institute (HHSN268200800007C), National Heart, Lung, and Blood Institute (N01HC85079), National Heart, Lung, and Blood Institute (N01HC85080), National Heart, Lung, and Blood Institute (N01HC85081), National Heart, Lung, and Blood Institute (N01HC85082), National Heart, Lung, and Blood Institute (N01HC85083), National Heart, Lung, and Blood Institute (N01HC85086), National Heart, Lung, and Blood Institute (U01HL080295), National Science Foundation (U.S.) (R01HL087652), National Heart, Lung, and Blood Institute (R01HL105756), National Heart, Lung, and Blood Institute (R01HL103612), National Heart, Lung, and Blood Institute (R01HL120393), National Institute on Aging (R01AG023629), National Center for Advancing Translational Sciences (U.S.) (UL1TR000124), National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (DK063491), National Heart, Lung, and Blood Institute (N01-HC-25195), National Heart, Lung, and Blood Institute (2K24HL04334), National Heart, Lung, and Blood Institute (R01HL077477), National Heart, Lung, and Blood Institute (R01HL093328), National Heart, Lung, and Blood Institute (NIH R01HL105993), National Institute on Aging (N01AG62101), National Heart, Lung, and Blood Institute (N01AG62103), National Heart, Lung, and Blood Institute (N01AG62106), National Institute on Aging (1R01AG032098-01A1), United States. National Institutes of Health (HHSN268200782096C), National Cancer Institute (U.S.) (CA-34944), National Cancer Institute (U.S.) (CA-40360), National Cancer Institute (U.S.) (CA-097193), National Heart, Lung, and Blood Institute (HL-26490), National Heart, Lung, and Blood Institute (HL-34595)